logo
Select company
Select metric
$ -182.75MEarning Before Interest & Taxes (EBIT)
VS
Market
6
Sector
11
Industry
15
History
8
$ 1.01Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information

Ticker

STRO

Company Name

SUTRO BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SUTRO BIOPHARMA INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STRO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -182.75M
3/31/2025$ -218.53M
12/31/2024$ -199.32M
9/30/2024$ -79.46M
6/30/2024$ -97.55M
3/31/2024$ -86.75M
12/31/2023$ -77.42M
9/30/2023$ -162.12M
6/30/2023$ -134.11M
3/31/2023$ -121.57M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) EBIT stands at $ 19.77M.
  • Over the past 5 years, SUTRO BIOPHARMA INC's average EBIT has been $ -109.12M.
  • The median EBIT for SUTRO BIOPHARMA INC during this period was $ -112.36M
  • SUTRO BIOPHARMA INC reached its highest EBIT over the past 5 years at $ 19.77M.
  • The lowest EBIT recorded by SUTRO BIOPHARMA INC in the same timeframe $ -218.53M

SUTRO BIOPHARMA INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
IPSC : CENTURY THERAPEUTICS INC $ -21.51MIGMS : IGM BIOSCIENCES INC $ -53.38MFBIO : FORTRESS BIOTECH INC $ -199KDOMH : DOMINARI HOLDINGS INC $ -19.02MMGX : METAGENOMI INC $ -90.29MASRT : ASSERTIO HOLDINGS INC $ -40.16MLUNG : PULMONX CORP $ -53.09MKPTI : KARYOPHARM THERAPEUTICS INC $ -78.76MICCC : IMMUCELL CORP $ 1.77MATRA : ATARA BIOTHERAPEUTICS INC $ 9.95M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

STRO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -218.53M

Minimum

Mar 31, 2025

$ 19.77M

Maximum

Sep 30, 2020

$ -109.12M

Average

$ -112.36M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M